«Биткоиномания»: прогнозы и возможности
Профиль Eurofins Cerep SA Provient regroupement
Eurofins-Cerep SA engages in providing preclinical drug research services. It uses its proprietary database BioPrint, which allows the modeling of clinical effects of drug candidates from molecular properties. The firm's services include compound management, high-throughput screening, in vitro safety profiling, assay development, and profile design. The company was founded by Thierry Jean on December 20, 1989 and is headquartered in Celle l'Evescault, France.